Get the Daily Brief
Latest Biotech News
Sepsis biology and potential precision targets
A new review in the Journal of Advanced Research describes how sepsis-driven lactate accumulation chemically rewrites proteins via lactylation, shifting regulated cell-death pathways across...
Neural data analytics for ICU deterioration risk
Researchers reported a machine-learning approach that combines automated whole-brain MRI segmentation with APACHE II and SOFA scores to flag sepsis-associated encephalopathy with an AUC of 0.92....
Gut microbiome shifts tied to diet-derived toxins and aging
Two new syntheses argue the gut microbiome is both a determinant and a target of mycotoxin toxicity. One perspective links microbial metabolism and barrier disruption to immune activation and...
Allergy diagnostics quality control for multiplex IgE panels
A landmark Korean study involving nearly 20,000 patients shows that multiplex IgE panels can disagree sharply even when tests sit in the same workflow. The research finds widely varying...
Machine learning for earlier kidney injury detection in ICU time series
A clinical study describes an AI model designed to forecast ICU vital signs and flag kidney injury earlier than conventional monitoring timelines. Using Temporal Fusion Transformer-style...
Hyperacusis intervention using gamified sound training
A preliminary clinical study suggests a two-week, daily game-based auditory training program can improve sound tolerance in adults with hyperacusis. Investigators report gains in noise acceptance...
CAR-T relapse biomarker from pre-treatment RNA splicing signals
Danish researchers report that low-level skipping of CD19 exon 2—detectable in pre-treatment RNA-seq—correlates with relapse after anti-CD19 CAR-T therapy. The study positions an accessible...
Primary care and clinical delivery constraints for rehabilitation access
A qualitative interview study in Belgium documents why physical therapy remains underused among advanced cancer patients. Patients, physicians, and physical therapists cite misaligned knowledge,...
Biotech regulation and real-world adoption of AI in hospitals
A landmark review warns that hospitals are deploying AI faster than regulators can keep up. The analysis highlights growing authorization volume in the US and points to ongoing mismatches between...
Targeted therapy in myotonic/generalized myasthenia: sequencing and crisis management
A real-world case series from a Greek neuromuscular center proposes practical sequencing strategies in generalized myasthenia gravis, pairing fast-acting FcRn antagonists with long-term immune...
Pan-European pancreatic cancer approval momentum
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) backed RevMed’s first-in-class pancreatic cancer therapy, according to a regulatory update. The recommendation...
FDA/US-Centre therapies and the business of AI-enabled diagnostics
A landmark review warns that US hospitals are deploying AI faster than regulators can keep up, creating a widening gap between authorization timelines and real-world use. The report highlights...
IPO and funding: RNAi bets expand beyond the liver
City Therapeutics raised fresh funding through an upsized IPO to accelerate RNA interference development with a goal of pushing beyond liver-only delivery. The company’s lead RNAi program is...
Brain stimulation analytics: how fast-growing deep-target techniques compare
A large comparative analysis challenges assumptions about how brain stimulation fields mature by mapping more than 32,000 publications. The study finds that temporal interference stimulation is...
Cancer precision oncology: digital pathology improves tumor DNA yield
QuantumCyte reported an AI-guided digital pathology approach designed to mask healthy tissue on solid tumor biopsies, improving the fraction of tumor DNA available for sequencing. The company...
Neurodegeneration and biomarker discovery: Parkinson’s blood immune signature tied to Alzheimer co-pathology
A multidimensional immunology study of early-stage Parkinson’s disease identified a hyperinflammatory, hypermetabolic blood signature that separates patients with Alzheimer’s co-pathology from...
Clinical evidence nuance: thrombectomy benefits in extended windows
A Bayesian network meta-analysis of 15 randomized trials found that endovascular thrombectomy delivers the clearest benefit for extended-window stroke patients with confirmed large-vessel...
Hidradenitis suppurativa: biologics reshape clot risk and outcomes
Two separate clinical signals in hidradenitis suppurativa (HS) point to evolving care impact. A retrospective study suggests that venous thromboembolism risk changes over the course of biologic...
Antibiotic stewardship evidence: shorter POET II regimens for endocarditis
The POET II trial supports stopping antibiotics once patients with infective endocarditis are clinically stable, potentially shortening treatment durations. The trial suggested relapse rates rise...
R&D and manufacturing infrastructure: GMP platform for extracellular vesicles
Researchers described a GMP-compliant, semi-automated manufacturing platform to generate clinical-grade extracellular vesicles (EVs) from Wharton’s jelly-derived mesenchymal stromal cells. The...